Medical Science Liaison (MSL) — Cardiovascular, Northeast

Job overview

The Medical Science Liaison (MSL) — Cardiovascular, Northeast role is remote, with candidates sought in the United States, ideally near a major airport hub. Compensation is not specified. The role represents the company and its recently approved PCSK9 inhibitor to cardiovascular stakeholders. The MSL facilitates scientific exchange about cardiovascular disease and the company’s product evidence, builds credible relationships across the medical community, and shares clinical insights internally. This work supports medical communications, publications, territory strategy, and coordinated scientific information sharing; travel may reach 60% of the time.

What you'll do

• Engage external stakeholders in scientific discussions about disease state and company product/portfolio evidence
• facilitate medical communications and publications by liaising between external and internal stakeholders
• build and maintain relationships with the cardiovascular medical community in academic and large community settings within lipidology
• assess key opinion leader alignment with the scientific platform
• monitor emerging literature and clinical data and translate it into knowledge exchange
• collect scientific and clinical insights
• travel up to 60% of the time.

What we're looking for

Skills & competencies

medical science liaison

msl

cardiovascular

northeast territory

remote

pcsk9 inhibitor

lipidology

scientific exchange

medical communications

clinical insights

up to 60% travel

tmac

Work arrangement

• Weekend coverage required

Why this role

Remote field-based role; cardiovascular and lipidology focus; represents a recently approved PCSK9 inhibitor; advanced scientific or clinical degree and at least 2 years of pharmaceutical-industry MSL experience required.

About the employer

TMAC is hiring for this role. Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Sector: 54.